# Uberlube, Inc. – FDA Inspection, Feb 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/uberlube-inc/a4c797c7-fa5c-4ffe-a70d-0d6e19e11b51
Source feed: FDA_Inspections

> FDA inspection 1197626 of Uberlube, Inc., February 16, 2023. Classification: No Action Indicated (NAI). 9 citations under 21 CFR parts 806 and 820. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197626
- Company Name: Uberlube, Inc.
- Inspection Date: 2023-02-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 9

## Related Documents

- [FDA Inspection 1084381 - 2019-03-29](https://www.keypedia.com/records/fda_inspections/uberlube-inc/c677c4f7-42f9-4af8-b0ad-fcb1fd2b8f20)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nicholas-z-lu/17448aca-e316-424c-b7b2-88c8baffc359)

Company: https://www.keypedia.com/companies/uberlube-inc/4f7ee440-4371-4c0e-a894-5885664547d7

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7